Stock A294090 EOFLOW CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News EOFLOW Co.,Ltd.

Equities

A294090

KR7294090006

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
11,990 KRW -6.98% Intraday chart for EOFLOW Co.,Ltd. -3.15% +187.19%
Feb. 08 EOFLOW Co.,Ltd. announced that it has received KRW 17 billion in funding from DB Financial Investment Co., Ltd., Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd., Tiger Investment Advisory Co.,Ltd., Hana Investment Banking & Securities Inc., Investment Arm CI
2023 EOFLOW Co.,Ltd. cancelled the transaction announced on May 25, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Preliminarily Enjoin Alleged Trade Secret Misappropriation Without Addressing A Time Bar Defense Under The DTSA?
AQ
EOFLOW Co.,Ltd. announced that it has received KRW 17 billion in funding from DB Financial Investment Co., Ltd., Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd., Tiger Investment Advisory Co.,Ltd., Hana Investment Banking & Securities Inc., Investment Arm
CI
EOFLOW Co.,Ltd. cancelled the transaction announced on May 25, 2023
CI
Medtronic Korea Holdings Co., Ltd. cancelled the acquisition of 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim.
CI
US-based Medtronic Acquires EOFlow
MT
Eoflow to Raise 314.9 Billion Won via Shares Issuance
MT
Medtronic Korea Holdings Co., Ltd. agreed to acquire a 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim for approximately KRW 170 billion.
CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 314.903773785 billion in funding from Medtronic Korea Holdings Co., Ltd.
CI
Pharmeo Inc. announced that it has received KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd.
CI
Pharmeo Inc. announced that it expects to receive KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd.
CI
EOFLOW Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
EOFLOW Co.,Ltd. announced that it has received KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd.
CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd.
CI
Pharmeo Inc. announced that it has received KRW 9.9078 billion in funding from EOFLOW Co.,Ltd.
CI
Pharmeo Inc. announced that it expects to receive KRW 9.9078 billion in funding from EOFLOW Co.,Ltd.
CI
Diabeloop and EOFLOW Co.,Ltd. Partners to Offer Wearable Aid with Smartphone App
CI
EOFlow Co., Ltd. Submits Application to the U.S. FDA for its Wearable Insulin Pump 'EOPatch'
CI
EOFLOW Co.,Ltd. and Zihipp Limited Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & Nash
CI
EOFLOW Co.,Ltd. announced that it has received KRW 9.2170284 billion in funding from Sinocare Inc.
CI
Biolinq Inc announced that it has received $100 million in funding from a group of investors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A294090 Stock
  4. News EOFLOW Co.,Ltd.